Human papillomavirus, human immunodeficiency virus and immunosuppression.
about
Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptakeThe Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in AfricaHPV Carcinomas in Immunocompromised PatientsTherapy of human papillomavirus-related diseaseAre we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancersAssociation of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional studyHPV infections among MSM in Shenzhen, China.Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populationsComprehensive control of human papillomavirus infections and related diseasesHuman papillomavirus detection in women with and without human immunodeficiency virus infection in ColombiaThe burden of human papillomavirus infections and related diseases in sub-saharan AfricaAccuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in KenyaCervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer.Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregiversUtilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.International scientific collaboration in HIV and HPV: a network analysis.Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysisHuman papillomavirus vaccination: current indications and future directionsCervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents.Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women.The Need for Cervical Cancer Control in HIV-Positive and HIV-Negative Women from Romania by Primary Prevention and by Early Detection Using Clinically Validated HPV/DNA TestsAcceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South AfricaPrevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study.The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, ZambiaModeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa.Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia.Human papillomavirus vaccination in HIV-infected women: need for increased coverage.Human Papillomavirus (HPV) Infections and the Importance of HPV Vaccination.Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected womenMultiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report.A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya.The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infectionPrevention, identification and treatment of vulvar squamous (pre)malignancies: a review focusing on quality of care.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.
P2860
Q26799457-F5FA82AA-1294-4004-8E7A-D2F17545CC0CQ26799584-CC4F6519-85A6-4C4A-80B2-8C4EFE22BF51Q26799629-76B6DF0D-9CE1-4AEB-965D-415C4D93F807Q27007473-F45E4DEC-306C-40A6-A651-7D0E2E1C1FB8Q28088322-F40DC13B-1BB9-473A-88EF-2C5EEB7492E1Q28388254-0C3FAF8F-B5A3-4887-976D-0145B8BC347FQ33572930-02DAE9F9-143F-485B-BE66-CA0A0A0A36ADQ33589738-8285E34B-F829-467A-AD29-8FD264868DFCQ33599099-208504BA-71D2-47F4-9AAF-B55463671148Q33772648-F7E2E02A-2421-43C6-86CA-B8769A1C9170Q33794306-9DBD0D2F-D6E2-440E-BAD2-1948436D4A8DQ34089781-68E70457-6476-4203-AC10-8ECD5F90D1C6Q34429237-54F19ACB-1344-495B-B464-538E6C120DCBQ34441738-2ADDDD2F-E95F-48B7-8133-BF453A56F6DBQ34710212-5CD1E3FE-A5EB-4315-B8FB-94E2BDD1EFFFQ34802726-62DD7141-97C2-47B2-B51B-59ECA501F47AQ34983504-8E68709F-3AF4-4B93-AB50-DCB815AC6556Q34994799-DF6AC7C5-C2E3-417C-926A-00318F991D64Q35135108-560907B8-D9D3-47DE-B251-789904EFEADCQ35413976-A931765B-78E4-49E6-9819-CC99C3440A5EQ35558593-77AE565C-88EC-4209-A66E-28043CAA66ACQ35628713-98E0329C-3B70-4E9E-9888-FAB9717F3650Q35655621-92DC5C55-9CD6-4705-AB0F-2A68CDDF6F02Q35694602-619B0483-3180-4BCB-AD01-F1057721F070Q35762277-B96E0424-0CFE-4C15-B3B4-E393832618A8Q35853643-CC20701C-4310-48E7-9099-D534670346F7Q36094880-4CA2BF73-C2C9-41CF-B370-8066A5C8564CQ36242558-3E04F775-27AB-4F7D-8121-4E7EE5F379D1Q36319807-6C28046E-70CA-42B6-A34A-00EDACA15F48Q36368353-48D1F597-45EB-49F4-92B3-422489615E53Q36560944-E6EA46FF-0A73-4843-B403-BCDA1BCBED64Q36656216-33155562-93F6-49D7-9806-E2C5B89FACA7Q36780952-019838A6-F6D9-42A9-8F86-56EFC9419544Q37155765-E02F4C4B-EAF0-4DF0-8BBC-AB353D709F72Q37470388-26577D13-8A6F-4997-ADED-57B30B7DFDA7Q37619549-73E80F0A-E474-48C2-8C32-B6514C64A812Q37630256-F1EE75B0-FD55-4E60-BA8F-99EA6B35F8E0Q37668390-A2251F85-3E90-4D72-A425-FC36D06819ECQ38123205-55724677-1FFC-4874-B591-100707BCDA86Q38194845-0571F841-B474-4010-B8FC-164CD79F4A4D
P2860
Human papillomavirus, human immunodeficiency virus and immunosuppression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Human papillomavirus, human immunodeficiency virus and immunosuppression.
@en
type
label
Human papillomavirus, human immunodeficiency virus and immunosuppression.
@en
prefLabel
Human papillomavirus, human immunodeficiency virus and immunosuppression.
@en
P2093
P1433
P1476
Human papillomavirus, human immunodeficiency virus and immunosuppression.
@en
P2093
Anna Barbara Moscicki
Isabelle Heard
Joel Palefsky
Lynette A Denny
P304
P356
10.1016/J.VACCINE.2012.06.045
P407
P478
30 Suppl 5
P577
2012-11-01T00:00:00Z